3SBio Inc. (HKG:1530)
16.06
-0.06 (-0.37%)
Sep 1, 2026, 4:08 PM HKT
3SBio Employees
3SBio had 6,068 employees as of June 30, 2026. The number of employees decreased by 41 or -0.67% since the number was reported on December 31, 2025.
Employees
6,068
Change
-41
Growth
-0.67%
Revenue / Employee
3.40M HKD
Profits / Employee
1.57M HKD
Market Cap
40.02B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 6,068 | -41 | -0.67% | 6,068 | 0 |
| Dec 31, 2025 | 6,109 | 532 | 9.54% | 6,109 | 0 |
| Dec 31, 2024 | 5,577 | 166 | 3.07% | 5,577 | 0 |
| Dec 31, 2023 | 5,411 | 198 | 3.80% | 5,411 | 0 |
| Dec 31, 2022 | 5,213 | -79 | -1.49% | 5,213 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 22,838 |
| Genscript Biotech | 6,135 |
| Shanghai Henlius Biotech | 4,082 |
| Akeso | 4,082 |
| RemeGen | 3,145 |
| Shanghai Junshi Biosciences | 3,055 |
| Keymed Biosciences | 1,625 |
| Biocytogen Pharmaceuticals (Beijing) | 1,443 |
3SBio News
- 12 days ago - 3SBio Earnings release: H1 2026 - Filings
- 5 months ago - 3SBio Earnings release: H2 2025 - Filings
- 5 months ago - 3SBio Annual report: H2 2025 - Filings
- 5 months ago - 3SBio Slides: H2 2025 - Filings
- 1 year ago - Pfizer Signs $6B Deal with 3SBio for China-Based Cancer Drug - TipRanks